Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07784387
A Study to Characterize High-Risk Non-Muscle-Invasive Bladder Cancer Participants in Portugal
Sponsor: Janssen-Cilag Farmaceutica Ltda.
View on ClinicalTrials.gov
Summary
The purpose of this study is to understand how the participants with high-risk non-muscle invasive bladder cancer are diagnosed, treated, and cared for in regular clinical practice in Portugal. HR-NMIBC is an early-stage bladder cancer that is limited to the inner lining of bladder but has a considerable high chance of cancer coming back or worsening.
Official title: High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) Retrospective Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2026-08-31
Completion Date
2028-02-29
Last Updated
2026-08-25
Healthy Volunteers
No
Conditions
Locations (1)
Ipo Lisboa
Lisbon, Portugal